Pierre Ruffiè

6.8k citations
76 papers · 5.3k · 1 hit paper · h-index 27

Impact in

    • Occupational and environmental lung diseases
    • Pleural and Pulmonary Diseases
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Medical Imaging and Pathology Studies
  • Oncology top 2%
    • Lung Cancer Research Studies

Papers in

    • Occupational and environmental lung diseases 20
    • Lung Cancer Treatments and Mutations 18
    • Pleural and Pulmonary Diseases 12
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
    • Lung Cancer Research Studies 24
    • Peptidase Inhibition and Analysis 6

Pierre Ruffiè

71 papers receiving 5.1k citations

Pierre Ruffiè's Hit Papers

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma 2003 · 2.5k citations
2.5k0+7+15Years since publication50010001.5k2.0k2.5k

Peers

Pierre Ruffiè
Comparison fields: 5 of 96
  • Pulmonary and Respiratory Medicine 3.5k
  • Oncology 1.3k
  • Neurology 391
  • Biotechnology 193
  • Epidemiology 611
Replace Gary M. Strauss with:
Gary M. Strauss United States
Juergen Dunst Germany
Gerrit DeBoer Canada
Noriyoshi Sawabata Japan
Vera A. Gorbounova Russia
Conrad B Falkson Canada
Stephen R. Smalley United States
Jeffrey M. Hardacre United States
Alana L. Christie United States
Jörg Michael Mezger Germany
Pierre Ruffiè relative to Gary M. Strauss United States Gary M. Strauss's profile →
Citations per field
00.5×2×3×4×4.7×
Gary M. Strauss · 1×
Citations per year

Countries citing papers authored by Pierre Ruffiè

Since Specialization
Citations

This map shows the geographic impact of Pierre Ruffiè's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Ruffiè with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Ruffiè more than expected).

Fields of papers citing papers by Pierre Ruffiè

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Ruffiè. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Ruffiè. The network helps show where Pierre Ruffiè may publish in the future.

Co-authors

The 25 scholars most cited alongside Pierre Ruffiè, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Ruffiè Line = papers co-authored together Pierre Ruffiè links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
Hit paper breakdown →
20032533
2 1989307
3 1991232
4 1998206
5 1993201
6 1996165
7 1979163
8 1994123
9 2003108
10 2003106
11 198592
12 200176
13 199871
14 200271
15 199660
16 200059
17 199854
18 199245
19 199945
20 199241

About Pierre Ruffiè

Pierre Ruffiè is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 76 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (24 papers), Occupational and environmental lung diseases (20 papers), Neuroendocrine Tumor Research Advances (19 papers), Lung Cancer Treatments and Mutations (18 papers), Pleural and Pulmonary Diseases (12 papers), Neuroblastoma Research and Treatments (10 papers), Peptidase Inhibition and Analysis (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.5k citations), Oncology (1.3k citations), Neurology (391 citations), Biotechnology (193 citations) and Epidemiology (611 citations). Pierre Ruffiè has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include Christian Manegold, James Thomas Symanowski, Claude A. Denham, Michael Joseph Boyer, Ulrich Gatzemeier, Salih Emri, James J. Rusthoven, Paolo Paoletti, Eckhard Kaukel and Nicholas J. Vogelzang. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, European Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact